Dr. Matthew Kadatz is a transplant nephrologist and researcher in the Division of Nephrology. His primary research focus is in the economic evaluation of kidney transplantation. Thus far, his research endeavours have led to the implementation of a program for the use of Hepatitis C positive organs in British Columbia, reducing discard and wait times for patients needing a kidney transplant, as well as a detailed economic analysis of funding of anti rejection medications in the US which has contributed to increasing insurance coverage for financially disadvantaged patients.
In addition to being co-investigator in multiple ongoing clinical trials, he is currently focused on improving the understanding of the economic value of deceased and living organ donors. The goal of this research, is to refocus resource allocation to improve organ donation rates and further reduce wait-times for kidney transplantation. This is a 3 year project in collaboration with BC Transplant and the Vancouver Coastal Health Research Institute.